New SEC Form D filing

BioGene Therapeutics Inc., 2026-08-07

A new SEC Form D private-offering notice from Austin, TX, a $3,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

BioGene Therapeutics Inc. site↗ Verified via SEC Form D

Develops gene therapies and bioresponsive lipid nanoparticle delivery technology targeting diabetes and obesity.

Filed 2026-08-07Filed to raise $3,000,000First money in 2026-06-05Raised so far $3,000,000HQ (as filed) Austin, TXSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified biogenetherapeutics.com↗Named in the filing 6 executives & directors
Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source